TRCT
CSCI

Tower Research Capital (TRC)’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Tower Research Capital (TRC)’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38
Closed -$105 – 5934
2024
Q4 		$105 Hold
38
– – ﹤0.01% 5466
2024
Q3 		$142 Buy
38
+3
+9% +$15 ﹤0.01% 5471
2024
Q2 		$155 Buy
+35
New +$267 ﹤0.01% 5441
2024
Q1 		– Hold
0
– -$2 – 6211
2023
Q4 		– Sell
-26
Closed -$192 – 5886
2023
Q3 		$258 Buy
+26
New +$289 ﹤0.01% 5632
2023
Q2 		– Sell
-3
Closed – – 6409
2023
Q1 		$0 Sell
3
-130
-98% -$1.73K ﹤0.01% 6364
2022
Q4 		$2K Buy
133
+13
+11% +$193 ﹤0.01% 5443
2022
Q3 		$2K Buy
120
+63
+111% +$1.21K ﹤0.01% 5632
2022
Q2 		$1K Hold
57
– – ﹤0.01% 5879
2022
Q1 		$2K Buy
+57
New +$2.05K ﹤0.01% 5621
2018
Q2 		– Sell
-1
Closed – – 4125
2018
Q1 		$0 Buy
+1
New +$196 ﹤0.01% 3930
2017
Q4 		– Sell
-14
Closed -$4K – 4099
2017
Q3 		$4K Buy
+14
New +$2.58K ﹤0.01% 3420
2017
Q2 		– Sell
-12
Closed -$4K – 3551
2017
Q1 		$4K Buy
12
+5
+71% +$1.47K ﹤0.01% 2361
2016
Q4 		$3K Buy
+7
New +$2.61K ﹤0.01% 3303
2016
Q3 		– Sell
-4
Closed -$2K – 4574
2016
Q2 		$2K Sell
4
-9
-69% -$3.24K ﹤0.01% 3982
2016
Q1 		$4K Buy
13
+11
+550% +$3.63K ﹤0.01% 2946
2015
Q4 		$1K Buy
+2
New +$1.26K ﹤0.01% 4189
2014
Q4 		– Sell
-2
Closed -$25K – 4781
2014
Q3 		$25K Hold
2
– – ﹤0.01% 2127
2014
Q2 		$25K Sell
2
-2
-50% -$22.3K ﹤0.01% 1714
2014
Q1 		$50K Buy
4
+3
+300% +$38.7K 0.01% 1096
2013
Q4 		$18K Buy
+1
New +$13.3K ﹤0.01% 2463
2013
Q3 		– Hold
0
– -$6K – 4894
2013
Q2 		– Hold
0
– – – 2833

Other funds holding CSCI

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Tower Research Capital (TRC)'s CSCI Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2025, closing a stake of 38 shares — an estimated $105 sold.

Tower Research Capital (TRC) first reported a position in CSCI in Q4 2013 and held it in 20 quarters. The position peaked at $50K in Q1 2014. 15 funds tracked by Wall St. Rank hold CSCI as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 38 COSCIENS Biopharma Inc. Common Stock shares in Q1 2025, an estimated $105.
  • Tower Research Capital (TRC) first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2013 and held it in 20 quarters.
  • Tower Research Capital (TRC)'s COSCIENS Biopharma Inc. Common Stock position peaked at $50K in Q1 2014.
  • 15 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.